Annual report [Section 13 and 15(d), not S-K Item 405]

Schedule I - Condensed Balance Sheet (Details)

v3.25.4
Schedule I - Condensed Balance Sheet (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
ASSETS        
Total assets $ 1,260,978 $ 1,802,321    
LIABILITIES        
Total liabilities 657,538 1,101,861    
STOCKHOLDERS' EQUITY        
Common stock 1,409 1,409    
Preferred stock 0 0    
Additional paid-in capital 1,108,525 1,106,792    
Accumulated deficit (248,634) (177,508)    
Treasury stock, at cost; shares 29,067,744 and 24,338,043 on December 31, 2025 and 2024, respectively (261,131) (222,826)    
Accumulated other comprehensive income (loss) 3,271 (7,407)    
Total equity 603,440 700,460 $ 705,464 $ 707,229
Total liabilities and equity 1,260,978 1,802,321    
Parent Company        
ASSETS        
Investment in subsidiaries 603,440 700,460    
Total assets 603,440 700,460    
LIABILITIES        
Total liabilities 0 0    
STOCKHOLDERS' EQUITY        
Common stock 1,409 1,409    
Preferred stock 0 0    
Additional paid-in capital 1,108,525 1,106,792    
Accumulated deficit (248,634) (177,508)    
Treasury stock, at cost; shares 29,067,744 and 24,338,043 on December 31, 2025 and 2024, respectively (261,131) (222,826)    
Accumulated other comprehensive income (loss) 3,271 (7,407)    
Total equity 603,440 700,460    
Total liabilities and equity $ 603,440 $ 700,460